肌钙蛋白阳性急性胸痛综合征中的心肌延迟对比增强CT
这项前瞻性研究纳入84例肌钙蛋白阳性急性胸痛且临床评估后诊断不明确的患者,行三重排除CT,若阴性则加做10分钟延迟对比增强CT。延迟增强CT将三重排除CT的诊断率从42/84(50%)提高到76/84(90%)(P < .001),并识别出心肌炎、takotsubo心肌病、淀粉样变等病因。
要点
- 肌钙蛋白阳性急性胸痛且临床评估不能确诊时,三重排除CT阴性后可加做延迟对比增强CT。
- 延迟增强CT可识别心肌炎、takotsubo心肌病、淀粉样变、非阻塞性冠脉心肌梗死等病因。
- 联合方案将诊断率从42/84(50%)提升至76/84(90%)(P < .001)。
核心结论
- 包含三重排除CT和延迟对比增强CT的CT方案提高了急性胸痛综合征患者的诊断率。
研究设计与样本
- 前瞻性研究,连续纳入2018年6月至2020年9月间因肌钙蛋白阳性急性胸痛或心绞痛等同症状、临床评估(症状、标志物、心电图和超声心动图)后诊断不明确并接受三重排除CT的患者84例(中位年龄69岁,四分位距50-77岁;男性45例)。
关键影像表现/征象
- 延迟对比增强CT可评估瘢痕的存在与模式,并定量心肌细胞外容积分数。
- 延迟增强CT诊断心肌炎22/42例(52%)、takotsubo心肌病4/42例(10%)、淀粉样变3/42例(7.1%)、非阻塞性冠脉心肌梗死3/42例(7.1%)、扩张型心肌病2/42例(4.8%),阴性或不确定8/42例(19%)。
诊断标准与关键数值
- 三重排除CT评估阻塞性冠心病(狭窄≥50%)、急性主动脉综合征和肺栓塞。
- 三重排除CT识别阻塞性冠心病35/84例(42%)、急性主动脉综合征1/84例(1.2%)、肺栓塞6/84例(7.1%)。
- 三重排除CT阴性者于10分钟后采集延迟对比增强CT。
- 联合延迟对比增强CT将诊断率从42/84(50%[95%CI:38.9,61.1])提高至76/84(90%[95%CI:82.1,95.8])(P < .001)。
- CT诊断与参考标准方法(包括有创冠状动脉造影、心脏MRI和心内膜心肌活检)比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Acute chest pain with mild troponin rise and inconclusive diagnosis after clinical evaluation represents a diagnostic challenge. Triple-rule-out (TRO) CT may exclude coronary artery disease (CAD), as well as acute aortic syndrome and pulmonary embolism, but cannot help identify other causes of myocardial injury. Purpose To investigate the diagnostic value of a comprehensive CT protocol including both an angiographic and a late contrast enhancement (LCE) scan in participants with troponin-positive acute chest pain. Materials and Methods In this prospective study, consecutive patients with troponin-positive acute chest pain or anginal equivalent and inconclusive diagnosis after clinical evaluation (symptoms, markers, electrocardiography, and echocardiography) who underwent TRO CT between June 2018 and September 2020 were enrolled. TRO CT was performed to evaluate the presence of obstructive CAD (stenosis ≥50%), acute aortic syndrome, and pulmonary embolism. If the findings on the TRO CT scan were negative, an LCE CT scan was acquired after 10 minutes to assess the presence and pattern of scar and quantify the myocardial extracellular volume fraction. CT-based diagnoses were compared with diagnoses obtained with reference standard methods, including invasive coronary angiography, cardiac MRI, and endomyocardial biopsy. Results Eighty-four patients (median age, 69 years [interquartile range, 50-77 years]; 45 men) were enrolled. TRO CT helped identify obstructive CAD in 35 participants (42%), acute aortic syndrome in one (1.2%), and pulmonary embolism in six (7.1%). LCE CT scans were acquired in the remaining 42 participants. The following diagnoses were reached with use of LCE CT: myocarditis (22 of 42 participants [52%]), takotsubo cardiomyopathy (four of 42 [10%]), amyloidosis (three of 42 [7.1%]), myocardial infarction with nonobstructed coronary arteries (three of 42 [7.1%]), dilated cardiomyopathy (two of 42 [4.8%]), and negative or inconclusive findings (eight of 42 [19%]). The addition of LCE CT improved the diagnostic rate of TRO CT from 42 of 84 participants (50% [95% CI: 38.9, 61.1]) to 76 of 84 (90% [95% CI: 82.1, 95.8]) (P < .001). Conclusion A CT protocol including triple-rule-out and late contrast enhancement CT scans improved diagnostic rate in participants presenting with acute chest pain syndrome. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Nagpal and Bluemke in this issue.
引用
- Palmisano, Vignale, Tadic, et al. Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome. Radiology. 2021. PMID: 34874200. doi:10.1148/radiol.211288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。